Molecule intelOpportunity: Lower0

Piperazine

25 brands · 23 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
19
Market saturation
59
Price room
0
Regulatory risk
50
25
brands
23
companies
Rs 118.75
median price
1
price points
1x
price spread
65
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 8%

Price room

Across observed sources and strengths
CheapestRs 118.75
MedianRs 118.75
Most expensiveRs 118.75
Spread1×
Sources: DVAGO, Servaid

Only 1 trusted price points; variation not scored (low data).

Brands & products on the market

Sample of 3 live products for Piperazine — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2023-11-24
Recall Alert: Drug Product; Piperazine Elixer (Batch # L-085) by Swat Pharmaceuticals, Swa

Why this score

Launch attractiveness

40% supply-gap(20) + 25% price-variation(0) + 20% low-competition(41) + 15% supply-disruption(40), damped by confidence(65). Higher = more attractive, less crowded opportunity.

Market saturation

23 canonical companies and 25 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

Only 1 trusted price points; variation not scored (low data).

Regulatory risk

1 DRAP alert(s), latest 2023-11-24 incl. recall/safety.

Confidence

Reduced by: sparse price data, no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.